Cargando…

Targeted Inhibition of CCL22 by miR-130a-5p Can Enhance the Sensitivity of Cisplatin-Resistant Gastric Cancer Cells to Chemotherapy

OBJECTIVE: This study set out to explore the regulatory mechanism of miR-130a-5p in cisplatin (DDP)-resistant gastric cancer (GC) cells. MATERIALS AND METHODS: Forty cases of GC and paracancerous tissues were collected, and the miR-130a-5p and CCL22 levels were detected by qRT-PCR. DDP-resistant cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Qing-Liang, Li, Kai-Chun, Wang, Lei, Gu, Xiang-Lian, Song, Ren-Jie, Lu, Song
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263884/ https://www.ncbi.nlm.nih.gov/pubmed/32547223 http://dx.doi.org/10.2147/CMAR.S249738

Ejemplares similares

Expression of miR-195 is associated with chemotherapy sensitivity of cisplatin and clinical prognosis in gastric cancer
por: Ye, Rui, et al.
Publicado: (2017)

miR-7 Increases Cisplatin Sensitivity of Gastric Cancer Cells Through Suppressing mTOR
por: Xu, Ning, et al.
Publicado: (2017)

miR-187/PDLIM1 Gets Involved in Gastric Cancer Progression and Cisplatin Sensitivity of Cisplatin by Mediating the Hippo-YAP Signaling Pathway
por: Tan, Yeru, et al.
Publicado: (2022)

Serum miR-191 and miR-425 as Diagnostic and Prognostic Markers of Advanced Gastric Cancer Can Predict the Sensitivity of FOLFOX Chemotherapy Regimen
por: Bie, Liang-Yu, et al.
Publicado: (2020)

MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells
por: Li, Ningwei, et al.
Publicado: (2015)

miR-22 in tumorigenesis
por: Song, Su Jung, et al.
Publicado: (2014)

Elevated miR-130a/miR130b/miR-152 expression reduces intracellular ATP levels in the pancreatic beta cell
por: Ofori, Jones K., et al.
Publicado: (2017)

Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
por: Li, Heng, et al.
Publicado: (2014)

Downregulated miR-130a enhances the sensitivity of acute myeloid leukemia cells to Adriamycin
por: Liu, Huimin, et al.
Publicado: (2020)

MiR-1208 Increases the Sensitivity to Cisplatin by Targeting TBCK in Renal Cancer Cells
por: Kim, Eun-Ae, et al.
Publicado: (2019)

Erratum to: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
por: Li, Heng, et al.
Publicado: (2014)

Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
por: Li, Heng, et al.
Publicado: (2022)

miR-130a-Mediated KLF3 Can Inhibit the Growth of Lung Cancer Cells
por: Wei, Ming-Chao, et al.
Publicado: (2021)

MiR-221 and miR-130a Regulate Lung Airway and Vascular Development
por: Mujahid, Sana, et al.
Publicado: (2013)

miR-130b duplex (miR-130b-3p/miR-130b-5p) negatively regulates goat intramuscular preadipocyte lipid droplets accumulation by inhibiting Krüppel-like factor 3 expression
por: Li, Yanyan, et al.
Publicado: (2023)

Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells
por: Lee, Sun Hee, et al.
Publicado: (2015)

miR-1271 enhances the sensitivity of colorectal cancer cells to cisplatin
por: Yao, Huixiang, et al.
Publicado: (2019)

CCL22 and CCL26 are potential biomarkers for predicting distant metastasis in thyroid carcinoma
por: Tong, Junyu, et al.
Publicado: (2022)

LINC01572 Regulates Cisplatin Resistance in Gastric Cancer Cells by Mediating miR-497-5p
por: Song, Zhe, et al.
Publicado: (2020)

CMPK1 Regulated by miR-130b Attenuates Response to 5-FU Treatment in Gastric Cancer
por: Chu, Huaizhu, et al.
Publicado: (2021)

The functional mechanism of miR-125b in gastric cancer and its effect on the chemosensitivity of cisplatin
por: Zhang, Xinyue, et al.
Publicado: (2017)

Clinical Significance of MiR-130b and MiR-125b as Biomarkers in Hepatocellular Carcinoma
por: El-Naidany, Sherin Sobhy, et al.
Publicado: (2022)

Serum miR-4530 sensitizes breast cancer to neoadjuvant chemotherapy by suppressing RUNX2
por: Wang, Xiao-Xiao, et al.
Publicado: (2018)

miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer
por: Yang, Dong, et al.
Publicado: (2017)

Circular RNA-ZFR Inhibited Cell Proliferation and Promoted Apoptosis in Gastric Cancer by Sponging miR-130a/miR-107 and Modulating PTEN
por: Liu, Tonglei, et al.
Publicado: (2018)

MiR-92a Inhibits the Progress of Osteosarcoma Cells and Increases the Cisplatin Sensitivity by Targeting Notch1
por: Liu, Quanxiang, et al.
Publicado: (2018)

Plasma Levels of miR-27a, miR-130b, and miR-301a in Polycystic Ovary Syndrome
por: Pourteymour Fard Tabrizi, Zahra, et al.
Publicado: (2020)

CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis
por: Lin, Xiaorong, et al.
Publicado: (2015)

Metformin Increases Sensitivity of Melanoma Cells to Cisplatin by Blocking Exosomal-Mediated miR-34a Secretion
por: Ge, Lan, et al.
Publicado: (2021)

Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer
por: Duan, Jingjing, et al.
Publicado: (2016)

MiR-26a Enhances the Sensitivity of Gastric Cancer Cells to Cisplatin by Targeting NRAS and E2F2
por: Wen, Lan, et al.
Publicado: (2015)

NRP1 is targeted by miR-130a and miR-130b, and is associated with multidrug resistance in epithelial ovarian cancer based on integrated gene network analysis
por: CHEN, CHANGXIAN, et al.
Publicado: (2016)

Infiltrating CD4+ T cells attenuate chemotherapy sensitivity in prostate cancer via CCL5 signaling
por: Xiang, Peng, et al.
Publicado: (2019)

Correction: The functional mechanism of miR-125b in gastric cancer and its effect on the chemosensitivity of cisplatin
por: Zhang, Xinyue, et al.
Publicado: (2020)

MiR‐130b promotes the progression of oesophageal squamous cell carcinoma by targeting SASH1
por: Zhu, Yuxing, et al.
Publicado: (2018)

p65/miR‐23a/CCL22 axis regulated regulatory T cells recruitment in hepatitis B virus positive hepatocellular carcinoma
por: Li, Zhi‐Qin, et al.
Publicado: (2019)

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
por: Qiu, Shuwei, et al.
Publicado: (2013)

Circ_0110805 Knockdown Enhances Cisplatin Sensitivity and Inhibits Gastric Cancer Progression by miR-299-3p/ENDOPDI Axis
por: Yang, Xi, et al.
Publicado: (2020)

Circulating miR‐130b‐ and miR‐21‐based diagnostic markers and therapeutic targets for hepatocellular carcinoma
por: Zhang, Nannan, et al.
Publicado: (2019)

A Chemotherapy-Driven Increase in Mcl-1 Mediates the Effect of miR-375 on Cisplatin Resistance in Osteosarcoma Cells
por: Liu, An-song, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nu9grqhluj7ejrn22luml93hpj